CURATIVE TECHNOLOGIES FILES SECONDARY OFFERING
CURATIVE TECHNOLOGIES FILES SECONDARY OFFERING EAST SETAUKET, N.Y., Nov. 22 /PRNewswire/ -- Curative Technologies,
Inc. (CTI) (NASDAQ: CURE) announced today that it has filed a registration statement with the Securities and Exchange Commission for an underwritten public offering of 1 million shares of its common stock by certain of the company's existing stockholders and may include 150,000 shares to be sold by such stockholders to cover over-allotments, if any. The selling stockholders do not include any of the company's management. Smith Barney, Harris Upham & Co., Inc., and Vector Securities International, Inc. are the managing underwriters.
Curative Technologies, Inc. is a biopharmaceutical company engaged in the research, development, production and marketing of therapeutic products utilizing naturally occurring human growth factors. The company's first product, Procuren(R), is a topical therapeutic which promotes wound healing and is produced from a patient's own blood. Procuren is sold through Wound Care Centers(R), which are cooperative ventures with selected hospitals. A copy of the prospectus relating to this offering can be obtained from either Smith Barney, Harris Upham & Co., Inc., 1345 Avenue of the Americas, New York, N.Y. 10105 or Vector Securities International, Inc. 1751 Lake Cook Road, Suite 350, Deerfield, Ill. 60015. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any such state. -0- 11/22/91 /CONTACT: John C. Prior, chief financial officer of Curative Technologies, 516-689-7000/ (CURE) CO: Curative Technologies, Inc. ST: New York IN: MTC SU: OFR PS -- NY006 -- 6233 11/22/91 08:31 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 22, 1991|
|Previous Article:||HOLOGIC AND OLDELFT ANNOUNCE THE TERMINATION OF AN INTERNATIONAL TRADE COMMISSION INVESTIGATION AND THE DISMISSAL OF A PATENT INFRINGEMENT SUIT|
|Next Article:||RESORT INCOME INVESTORS INC. ANNOUNCES NEW ORLEANS INVESTMENT|